Evogene Ltd. | Income Statement
Fiscal year is January-December. All values ILS Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
63,458.80
51,908.70
43,238.60
25,105.50
12,161.40
6,280.90
Cost of Goods Sold (COGS) incl. D&A
40,228.00
39,202.50
37,803.20
28,092.10
16,837.40
11,903.90
Gross Income
23,230.80
12,706.20
5,435.40
2,986.60
4,676.10
5,623
SG&A Expense
54,709.30
67,279.90
75,062.40
77,969.20
74,266.70
70,790.70
EBIT
31,478.50
54,573.70
69,627.00
80,955.70
78,942.80
76,413.70
Unusual Expense
4,125.70
4,707.60
6,480.50
2,798.50
2,856.00
5,051.30
Non Operating Income/Expense
115.50
64.40
159.30
65.30
295.00
2,175.10
Interest Expense
314.00
715.40
757.60
595.00
464.00
506.90
Pretax Income
32,045.20
51,976.60
66,876.30
75,070.90
74,914.20
74,716.80
Income Tax
-
-
-
138.20
39.60
107.90
Consolidated Net Income
32,045.20
51,976.60
66,876.30
75,209.10
74,953.80
74,824.60
Net Income
32,045.20
51,976.60
66,876.30
75,209.10
74,953.80
74,630.50
Net Income After Extraordinaries
32,045.20
51,976.60
66,876.30
75,209.10
74,953.80
74,630.50
Net Income Available to Common
32,045.20
51,976.60
66,876.30
75,209.10
74,953.80
74,630.50
EPS (Basic)
1.62
2.07
2.64
2.96
2.91
2.90
Basic Shares Outstanding
19,532.00
25,100.60
25,378.30
25,444.70
25,673.30
25,753.40
EPS (Diluted)
1.64
2.07
2.64
2.96
2.92
2.90
Diluted Shares Outstanding
19,532.00
25,100.60
25,378.30
25,444.70
25,673.30
25,753.40
EBITDA
24,111.50
46,528.60
60,166.50
72,211.00
71,227.30
69,151.30
Non-Operating Interest Income
3,757.50
7,955.70
9,829.60
9,213.00
7,643.60
5,080.10
About Evogene
View Profile
